-
[1]
吴颖运, 洪坤学, 耿运琪, 邵一鸣, 2004: The Application of Live Attenuated SHIV in AIDS Vaccine Research, Virologica Sinica, 19, 187-191.
-
[2]
Bei Wang, Chongyang Zhang, Xiaobo Lei, Lili Ren, He Huang, Jianwei Wang, Zhendong Zhao, 2021: Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation, Virologica Sinica, 36, 890-900. doi: 10.1007/s12250-021-00369-9
-
[3]
Yi-ming SHAO, 2007: AIDS Research and Its Role in China's AIDS Prevention and Control Policies, Virologica Sinica, 22, 421-423.
-
[4]
蒋岩, 1997: Research advances of animal models of murine AIDS for evaluation of anti - AIDS treatment, Virologica Sinica, 12, 1-.
-
[5]
朱义鑫, 刘畅, 乔文涛, 陈启民, 耿运琪, 曾毅, 2005: Construction and Characterization of SHIV Carrying HIV-1 Capsid, Virologica Sinica, 20, 346-351.
-
[6]
Susan L. Uprichard, 2010: Hepatitis C Virus Experimental Model Systems and Antiviral drug Research*, Virologica Sinica, 25, 227-245. doi: 10.1007/s12250-010-3134-0
-
[7]
陆宇, 陈建国, 丁明孝, 1996: Research progress on hog cholera virus and its vaccine, Virologica Sinica, 11, 201-.
-
[8]
卢曾军, 曹轶梅, 刘在新*, 谢庆阁, 2006: Advance of Adenoviral Vector in Gene Therapy and Vaccine Research, Virologica Sinica, 21, 622-626.
-
[9]
Yun-Yun Jin, Hanwen Lin, Liu Cao, Wei-Chen Wu, Yanxi Ji, Liubing Du, Yiling Jiang, Yanchun Xie, Kuijie Tong, Fan Xing, Fuxiang Zheng, Mang Shi, Ji-An Pan, Xiaoxue Peng, Deyin Guo, 2021: A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery, Virologica Sinica, 36, 913-923. doi: 10.1007/s12250-021-00385-9
-
[10]
郑永唐, 贲昆龙, 王金焕, 齐瑾, 黄生民, 1997: Establishment and application of an experimental model for screening anti - AIDS drugs with simian type D retrovirus, Virologica Sinica, 12, 61-.
-
[11]
寸韡, 刘龙丁, 张莹, 罗杰, 吴文娟, 张雪梅, 廖芸, 李琦涵*, 2006: Construction and Application of Eukaryotic Expression Vector phIE Containing HSVI α-gene Promoter, Virologica Sinica, 21, 328-323.
-
[12]
李宏玲, 李河民, 俞永新, 严子林, 1990: Application of Plaque Assay Method for Rabies Virus in the Study of Virus and Vaccine, Virologica Sinica, 5, 135-.
-
[13]
李建娜, 向开军, 周荣, 丁勇强, 白培胜, 张裕平, 朱冰, 曾其毅, 2005: Expression of SARS Coronavirus Membrane Protein and its DNA Vaccine Construction, Virologica Sinica, 20, 113-116.
-
[14]
尚大庄, 王永祥, 王玉坤, 顾葆良, 1989: Experimental Research and Application of Polyacrylamide Gel Debris Absorption and Elution Method for Virus Concentration, Virologica Sinica, 4, 199-.
-
[15]
李萍, 严家新, 朱家鸿, 1997: Research on DNA vaccine carrying the rabies virus glycoprotien gene and its immune protection effects, Virologica Sinica, 12, 142-.
-
[16]
姬向波, 刘文波, 魏建超, 牛明福, 周斌, 曹瑞兵, 陈溥言*, 2006: Construction and Immune Effect of the Recombinant DNA Vaccine Expressing ILTV Major Antigen Epitope gene, Virologica Sinica, 21, 481-484.
-
[17]
余兴龙, 涂长春, 李红卫, 陈创夫, 李作生, 马正海, 孙明, 殷震, 2000: Construction of Enkaryotie Expression Plasm ids of CSFV E2 Gene and the Study on DNA Vaccine, Virologica Sinica, 15, 264-271.
-
[18]
沈弢, 张晓燕, 南昌龙, 童骁, 范秀娟, 沈荣显, 邵一鸣, 2005: Construction and Characterization of EIAV Vaccine Infectious Clones Labeled with FLAGTM or 6 His-tag, Virologica Sinica, 20, 257-261.
-
[19]
Yi ZENG, 2007: Strategy for AIDS Prevention and Treatment, Virologica Sinica, 22, 419-420.
-
[20]
Yuqian Yan, Shuping Jing, Liqiang Feng, Jing Zhang, Zhiwei Zeng, Min Li, Shan Zhao, Junxian Ou, Wendong Lan, Wenyi Guan, Xiaowei Wu, Jianguo Wu, Donald Seto, Qiwei Zhang, 2021: Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: "Adenovirus Vaccine Within an Adenovirus Vector", Virologica Sinica, 36, 354-364. doi: 10.1007/s12250-020-00234-1